What we have achieved
Our research is helping countries replace older, difficult–to–use, and sometimes ineffective formulations and scale up new, optimum treatments for young children.
New hope for children co-infected with HIV and TB. Drugs used to treat tuberculosis can interfere with HIV treatment, reducing its effectiveness. A successful study with our South African partners paved the way for better treatment for children living with both diseases.
What we are doing for children living with HIV
In order to help end the neglect of babies and young children with HIV, we have developed an easy-to-administer, strawberry-flavoured ‘4-in-1’ treatment together with the Indian company Cipla. But our engagement goes well beyond drug development alone. Through a series of partnerships, we are working to ensure improved treatments for kids are rolled out where they are needed most.
A strawberry-flavoured, ‘4-in-1’ treatment for children. The 4-in-1 meets the treatment needs of the youngest children living with HIV. The combination of four antiretrovirals in easy-to-administer, heat-stable, strawberry-flavoured granules has been approved in South Africa
One of the largest paediatric HIV cohorts in the world. Our implementation study with over 1,000 children in Kenya, Uganda, and Tanzania was designed to help improve uptake of newer treatments for kids.
Making medical history for neglected patients
We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.